Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SGI Venture Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 17
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 17
Rounds per year 1.06
Lead investments 1
Key employees Soon

Areas of investment

  • Medical
  • Health Care
  • Information Technology
  • Software
  • Biotechnology
Summary

SGI Venture Capital is the famous VC, which was founded in 2007. The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the SGI Venture Capital, startups are often financed by Entrepreneur First, Kakao Ventures. The meaningful sponsors for the fund in investment in the same round are Mega Investment, Entrepreneur First, Charlie Songhurst. In the next rounds fund is usually obtained by Songhyun Investment, Neoplux, MG Investment.

The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - South Korea. Among the most successful fund investment fields, there are Artificial Intelligence, Security. Among the most popular portfolio startups of the fund, we may highlight Insignary, Watcha.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SGI Venture Capital:
Typical Co-investors
SGI Venture Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SGI Venture Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accurafy Advisory Luxembourg, Luxembourg
Axa XL Bermuda, Hamilton
Bullnet Capital Madrid, Pozuelo De Alarcón, Spain
Chishan Group China, Japan, Kagoshima Prefecture
Fingerhut Ventures Eden Prairie, Minnesota, United States
Infinion Biopharma Ahmedabad, Gujarat, India
Peking University Mingde Fund Beijing, China, Haidian
Xiamen Wenguang Touzi Guanli Co., Ltd. China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

VSI

Automotive
Mechanical Design
Mechanical Engineering
$6M12 Jan 2023 South Korea, Gangwon-do, South Korea

TradLinx Co.

Consulting
Shipping
$6M15 Nov 2022 South Korea, Gyeonggi-do, South Korea

PineTree Therapeutics

Medical
Therapeutics
Wellness
$23M07 Jun 2022 Cambridge, Massachusetts, United States

Novelty Nobility

Biotechnology
Health Care
Life Science
Therapeutics
$29M13 May 2022 Seongnam, Kyonggi-do, South Korea

Triz

Brand Marketing
Commercial
Content Creators
E-Commerce
Social Media Marketing
$6M18 Apr 2022 Seoul, Seoul-t'ukpyolsi, South Korea

Angel Robotics

Medical Device
Robotics
Wholesale
$15M29 Sep 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Wiju

Advertising
Marketing
$1M04 May 2021 South Korea, Gangwon-do, South Korea

Master Meditech

Chemical
Medical
Product Research
Venture Capital
$6M31 Mar 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Biobab AiBIO

Artificial Intelligence
Biotechnology
Medical
Pharmaceutical
$13M15 Mar 2021 South Korea, Gangwon-do, South Korea

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SGI Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 17
Average round size 7M
Rounds per year 1.06
Peak activity year 2021
Lead investments 1
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

VSI

Automotive
Mechanical Design
Mechanical Engineering
$6M12 Jan 2023 South Korea, Gangwon-do, South Korea

TradLinx Co.

Consulting
Shipping
$6M15 Nov 2022 South Korea, Gyeonggi-do, South Korea

PineTree Therapeutics

Medical
Therapeutics
Wellness
$23M07 Jun 2022 Cambridge, Massachusetts, United States

Novelty Nobility

Biotechnology
Health Care
Life Science
Therapeutics
$29M13 May 2022 Seongnam, Kyonggi-do, South Korea

Triz

Brand Marketing
Commercial
Content Creators
E-Commerce
Social Media Marketing
$6M18 Apr 2022 Seoul, Seoul-t'ukpyolsi, South Korea

Angel Robotics

Medical Device
Robotics
Wholesale
$15M29 Sep 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Wiju

Advertising
Marketing
$1M04 May 2021 South Korea, Gangwon-do, South Korea

Master Meditech

Chemical
Medical
Product Research
Venture Capital
$6M31 Mar 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Biobab AiBIO

Artificial Intelligence
Biotechnology
Medical
Pharmaceutical
$13M15 Mar 2021 South Korea, Gangwon-do, South Korea
Crunchbase icon

Content report

The following text will be sent to our editors: